211 related articles for article (PubMed ID: 17107609)
1. Treatment of polydrug-using opiate dependents during withdrawal: towards a standardisation of treatment.
Kristensen Ø; Lølandsmo T; Isaksen A; Vederhus JK; Clausen T
BMC Psychiatry; 2006 Nov; 6():54. PubMed ID: 17107609
[TBL] [Abstract][Full Text] [Related]
2. [Detoxification of poly-substance abusers with buprenorphine. Effects on affect, anxiety, and withdrawal symptoms].
Paetzold W; Eronat V; Seifert J; Holze I; Emrich HM; Schneider U
Nervenarzt; 2000 Sep; 71(9):722-9. PubMed ID: 11042867
[TBL] [Abstract][Full Text] [Related]
3. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
5. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Ohlmeier M; Passie T; Hauser U; Becker H; Wiese B; Emrich H; Schneider U
Addict Biol; 2005 Jun; 10(2):157-64. PubMed ID: 16191668
[TBL] [Abstract][Full Text] [Related]
6. Standardised detoxification in cases of polydrug use.
Dunsæd F; Kristensen Ø; Vederhus JK; Clausen T; Høie MM
Tidsskr Nor Laegeforen; 2016 Oct; 136(19):1639-1642. PubMed ID: 27790891
[TBL] [Abstract][Full Text] [Related]
7. Topiramate in opiate withdrawal- comparison with clonidine and with carbamazepine/mianserin.
Zullino DF; Krenz S; Zimmerman G; Miozzari A; Rajeswaran R; Kolly S; Khazaal Y
Subst Abus; 2004 Dec; 25(4):27-33. PubMed ID: 16172090
[TBL] [Abstract][Full Text] [Related]
8. Combined buprenorphine and chlonidine for short-term opiate detoxification: patient perspectives.
Wallen MC; Lorman WJ; Gosciniak JL
J Addict Dis; 2006; 25(1):23-31. PubMed ID: 16597570
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine and carbamazepine as a treatment for detoxification of opiate addicts with multiple drug misuse: a pilot study.
Schneider U; Paetzold W; Eronat V; Huber TJ; Seifert J; Wiese B; Emrich HM
Addict Biol; 2000 Jan; 5(1):65-9. PubMed ID: 20575820
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine and valproate as adjuncts in the treatment of alcohol withdrawal syndrome: a retrospective cohort study.
Eyer F; Schreckenberg M; Hecht D; Adorjan K; Schuster T; Felgenhauer N; Pfab R; Strubel T; Zilker T
Alcohol Alcohol; 2011; 46(2):177-84. PubMed ID: 21339186
[TBL] [Abstract][Full Text] [Related]
11. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Collins ED; Kleber HD; Whittington RA; Heitler NE
JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
[TBL] [Abstract][Full Text] [Related]
12. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
[TBL] [Abstract][Full Text] [Related]
13. Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal.
Carnwath T; Hardman J
Drug Alcohol Depend; 1998 May; 50(3):251-4. PubMed ID: 9649979
[TBL] [Abstract][Full Text] [Related]
14. Benzodiazepines, methadone and buprenorphine: interactions and clinical management.
Lintzeris N; Nielsen S
Am J Addict; 2010; 19(1):59-72. PubMed ID: 20132123
[TBL] [Abstract][Full Text] [Related]
15. Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment.
Kowalczyk WJ; Phillips KA; Jobes ML; Kennedy AP; Ghitza UE; Agage DA; Schmittner JP; Epstein DH; Preston KL
Am J Psychiatry; 2015 Aug; 172(8):760-7. PubMed ID: 25783757
[TBL] [Abstract][Full Text] [Related]
16. Use of anticonvulsants in benzodiazepine withdrawal.
Pages KP; Ries RK
Am J Addict; 1998; 7(3):198-204. PubMed ID: 9702287
[TBL] [Abstract][Full Text] [Related]
17. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
Gold MS
Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
[TBL] [Abstract][Full Text] [Related]
18. Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine.
White R; Alcorn R; Feinmann C
Drug Alcohol Depend; 2001 Dec; 65(1):77-83. PubMed ID: 11714592
[TBL] [Abstract][Full Text] [Related]
19. Outpatient opiate detoxification with clonidine.
Washton AM; Resnick RB
J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
[TBL] [Abstract][Full Text] [Related]
20. Detoxification and treating opioid dependence.
de Jong CJ
JAMA; 2006 Feb; 295(8):887; author reply 887-8. PubMed ID: 16493098
[No Abstract] [Full Text] [Related]
[Next] [New Search]